Clinical trial
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem…
NCT00003680 · Scottish Cancer Therapy Network, Other · Unknown status
Key facts
| NCT number | NCT00003680 |
|---|---|
| Title | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer |
| Official title | A Randomised Comparative Trial of Highly Intensive Chemotherapy With Stem Cell Support vs. Relatively Intensive Chemotherapy (CMF 8 Cycles) in Breast Cancer Patients Node Positive Surgery, Having Received Primary Medical Therapy With an Anthracycline Regimen |
| Lead sponsor | Scottish Cancer Therapy Network, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | CMF regimen, cyclophosphamide, fluorouracil, methotrexate, tamoxifen citrate, thiotepa, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 300 |
| Start date | Nov 1, 1998 |
| First posted | May 3, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: